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Abstract
The manipulation of magnetic nanoparticles (MNPs) using an external magnetic field, has been successfully demonstrated in 
various biomedical applications. Some have utilised this non-invasive external stimulus and there is an potential to build on 
this platform. The focus of this study is to understand the manipulation of MNPs by a time-varying static magnetic field and 
how, at different frequencies and displacement, this can alter cellular function. Here we explore, using numerical modeling, 
the physical mechanism which underlies this process, and we discuss potential improvements for its use in biomedical appli-
cations. From our data and other related studies, we infer that such phenomenon largely depends on the magnetic field gradi-
ent, magnetic susceptibility and size of the MNPs, magnet array oscillating frequency, viscosity of the medium surrounding 
MNPs, and distance between the magnetic field source and MNPs. Additionally, we demonstrate cytotoxicity in neuroblastoma 
(SH-SY5Y) and hepatocellular carcinoma (HepG2) cells in vitro induced by MNPs exposed to a magnetic field gradient and 
oscillating at various frequencies and displacement amplitudes. Even though this technique reliably produces MNP endocytosis 
and/or cytotoxicity, a better understanding is required to develop this system for precision manipulation of MNPs, ex vivo.
1 Introduction
The manipulation of magnetic nanoparticles (MNPs) using 
external magnetic fields has led to the emergence of novel 
in vitro technologies. This technique which relies on non-
invasive external stimuli, such as gradient magnetic field-
assisted bioseparation [1] and gene transfection [2, 3]; alter-
nating field gradient-mediated cytotoxicity [4]; dynamic 
magnetic field (DMF)-mediated cytotoxicity [5]; alternating 
magnetic field (AMF)-mediated cytotoxicity [6]; and con-
trolled drug release [7]. The techniques mentioned above 
involve both permanent magnets and electromagnets with 
different working principles. Bioseparation consists of the 
use of a field gradient to capture specific biomolecules which 
are bound to MNPs [8]. Magnetofection involves the use of a 
magnetic field to attract magnetic nanoparticles and nucleic 
acid complexes towards cells to facilitate gene transfection 
[9, 10]. The alternating field gradient mediated cytotoxicity 
technique uses an alternating field gradient (Gz–95 G/cm) 
within a homogenous field (a 9.4 T preclinical MRI sys-
tem) to align the nanoparticles parallel to the homogenous 
field and destroy cancer cells through an induced motion of 
magnetic nanoparticle aggregates within cells [4]. Dynamic 
magnetic fields (10–20 Hz, 30 mT) encourage torques, 
i.e., repeated incomplete rotational movements, of MNPs 
which enables remote stimulation of cell death by permea-
bilising the lysosome membrane and triggering apoptosis 
(programmed cell death) [5]. The application of alternating 
magnetic fields (50–1000 kHz) to MNPs which are bound to 
receptors on cell membranes or internalized within cells, has 
been used to activate chemical signaling in the cell, leading 
to apoptosis or the depositing of energy, triggering necrosis 
(cell death or tissue damage in an organ) [11].
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The possible physical explanations for the static magnetic 
field gradient-mediated attracting/aligning of MNPs towards 
a magnet field have been discussed extensively [12–15]. 
Moreover, a possible mechanism for alternating field gradi-
ent mediated cytotoxicity has been examined [4]. However, 
an explanation for dynamic field-induced rotational motion 
has proven elusive; it is stated in [4] that a dynamic field 
generates a torque, equal to and that this enables the rota-
tion of individual MNPs around their axis, but the dynam-
ics of the magnetic fields used requires further exploration. 
Moreover, deposition of energy is possible when MNPs are 
exposed to alternating magnetic fields in the radio frequency 
range, since they dissipate heat due to susceptibility, hyster-
esis and friction losses [12].
This study focuses on the underlying conditions behind 
the manipulation of MNPs using unidirectional time-varying 
magnetic fields/field gradients and how this can induce mag-
neto-mechanical cell death in cancer cells. The numerical 
model discussed here will direct researchers to this novel 
technique. Here, we used a time-varying (1–4 Hz) alternate 
pole magnet array plate populated with Nd–Fe–B permanent 
magnets (~ 450 mT) to create field gradients which result in 
enhanced attraction of magnetic nanoparticle towards cells 
which led to cytotoxicity in neuroblastoma (SH-SY5Y) and 
hepatocellular carcinoma (Hep G2) cancer cells.
2  Materials and methods
2.1  Magnetic field measurements
Magnetic field measurements of three different 3 × 3 
Nd–Fe–B magnet arrays were performed using a Hall probe 
(F.W.Bell–5080 Teslameter; Orlando, Florida, USA). The 
numerical modeling discussed in this paper was carried out 
using the Sim4Life (ZMT Zurich MedTech, Zurich, Swit-
zerland) platform. The dimensions of the magnets and the 
corresponding distances were measured in relation to the 
magnet array which was explicitly fabricated for performing 
the experiments here.
2.2  Mathematical model
These measurements were used to calculate the magnetic field 
(flux density, T) of each 3 × 3 array (Fig. 1), the magnetic force 
(N) experienced by the MNPs, and the gradient field (gradient 
flux density; T/m) for specific distances from the magnet faces 
along the z-axis (0 mm, 1 mm, 1.5 mm) and from the centre of 
each magnet along the y-axis (− 3 to + 3 mm; 2D plot).
The magnetic field was calculated using the magnetic vec-
tor potential (A) under the assumption that ∇ ⋅ (B) = 0 and 
B = ∇ × (A) , i.e.:
where J0 is the surface current density (A/m).
In addition, to explain the aforementioned phenomenon 
(magneto-mechanical cell death), the following mathematical 
model can be used.
The magnetic moment, m, of a nanoparticle (based on the 
typical design of having magnetic material at the core) is a 
product of its magnetization, M, and volume, Vm = 43휋R
3
m
 , 
where Rm is the radius of its magnetic core:
The volumetric magnetization of the MNPs is induced by 
application of the external magnetic field, H,
where Δ휒 is the effective susceptibility of the MNPs with 
respect to the medium (water) and:
Assuming that the relative permeability of the water, 
휇r = 1 , together with B = 휇0H , the volumetric magnetiza-
tion can be introduced as:
and
Furthermore, if MNPs are point dipoles with the same 
moment, m, the force experienced by them is
Combining (6) and (7), we get
(1)∇ ×
1
휇
∇ × A = J0,
(2)m = MVm.
(3)M = Δ휒H,
(4)Δ휒 = 휒MNP − 휒water.
(5)M =
Δ휒B
휇0
,
(6)m =
Δ휒V
m
B
휇0
.
(7)Fm = (m ⋅ ∇)B.
Fig. 1  Illustration of the alternate pole magnet array, made up of Nd–
Fe–B permanent rare earth magnets, which was used for the induc-
tion of magneto-mechanical cytotoxicity in cancer cells. Dimensions 
of the magnet used (height, diameter) and the populated magnet array 
(cross section) connected to the oscillator are provided
Remote manipulation of magnetic nanoparticles using magnetic field gradient to promote cancer…
1 3
Page 3 of 10   226 
Knowing that ∇ × B = 0 , the force on the dipole can be 
modified as:
To be effective, Fm must overcome the hydrodynamic 
drag force, Fd, acting on the MNPs, i.e.,
where 휂 is the viscosity of the medium (water) surrounding 
the MNPs, Rh is the hydrodynamic radius, and vm is the drift 
velocity ( Δv
m
= vMNP − vwater ). The MNPs will be immobi-
lized when Fd = Fm, so:
or
where 휉 is the magnetophoretic mobility.
As the first approximation, it can be assumed that 
Rm = Rh and when
As the second approximation, it can be assumed that 
Rm ≠ Rh and when
where Vh =
(
1 +
훿
Rm
)3
Vm and 훿 is the thickness of the 
absorbed surface layer.
2.3  Cell culture
Human neuroblastoma cells (SH-SY5Y; CRL-2266; Ameri-
can Type Culture Collection, Manassas, USA) were main-
tained as described previously [16]. SH-SY5Y cells were 
seeded at a density of 1 or 2 × 104 cells in 100 µl medium 
(8)Fm = (m ⋅ ∇)B =
V
m
Δ휒
휇0
(B ⋅ ∇)B.
(9)
F
m
=
V
m
Δ휒
2휇0
∇(B ⋅ B) =
V
m
Δ휒
2휇0
∇B2 = V
m
Δ∇
(
1
2
B ⋅ H
)
.
(10)Fd = 6휋휂RhΔvm,
(11)6휋휂RhΔvm =
4R3
m
Δ휒
6휇0
∇B2,
(12)Δvm =
R3
m
Δ휒
9휇0휂Rh
∇B2 = 휉∇B2,
(13)휉 =
R2
m
Δ휒
9휇0휂
.
(14)휉 =
R3
m
Δ휒
9휇0휂Rh
,
onto uncoated 96-well plates in Ham’s F12: MEM (1:1) 
supplemented with 10% fetal bovine serum (FBS), 2 mM 
l-glutamine, 100 U penicillin, and 0.1 mg/ml streptomycin. 
Human hepatocellular carcinoma cells (Hep G2; HB-8065; 
American Type Culture Collection, Manassas, USA) were 
cultured in DMEM with 10% FBS, 2 mM L-glutamine, 100 
U penicillin, and 0.1 mg/ml streptomycin, prior to seeding 
at a density of 1 or 2 × 104 cells in 100 µl medium onto rat 
tail collagen I-coated 96-well plates. Cultured cells were 
incubated at 37 °C, 5%  CO2, for 24 h prior to cytotoxicity 
experiments.
2.4  Magnetic field gradient‑mediated cytotoxicity 
experiments
Magnetite nanoparticles were obtained from Ozbiosciences, 
Marseilles, France (Polymag MNPs, used with SH-SY5Y 
cells) and nanoTherics Ltd, Staffordshire, UK (nTmag 
MNPs, used with Hep G2 cells). Both Polymag and nTmag 
contains a magnetite core. They range between 100 and 
250 nm in hydrodynamic diameter and are surface function-
alized with proprietary polyethyleneimine derivative. Both 
have positive zeta potential (surface charge). The rationale 
for using both particles is that the study was aimed at evalu-
ation of MNP + magnet array-mediated cancer cytotoxic-
ity. Our goal was to demonstrate that the technology works 
efficiently with different commercially available magnetic 
nanoparticles that have been widely demonstrated to show 
high biocompatibility [10, 17]. MNPs were diluted in 100 µl 
medium and added to cell cultures (0.2 µl per well) immedi-
ately prior to magnetic field application. Cell culture plates 
were placed over the magnet array, with cells 1 mm above 
magnet surface, along the z-axis. Magnet array oscillated 
along the x-axis using a stepper motor for 30 min with the 
indicated frequencies and displacements. The experiment 
was conducted within a 37 °C, 5%  CO2, tissue culture incu-
bator during the 30-min exposure.
2.5  Cell viability assay
After exposure to the oscillating magnet array, cell culture 
plates were returned to the incubator for 48 h before viabil-
ity testing. The CytoTox-ONE™ membrane integrity assay 
(Promega, Southampton, UK) provided a measurement 
of the amount of lactate dehydrogenase (LDH) released 
through damage to cell membranes. The assay was per-
formed according to the manufacturer’s instructions, and 
luminescence was recorded using a plate reader (BioTek, 
Bedfordshire, UK).
% viability = 100 −
[
100
[
experimental − backgrond luminescence
maximum LDH release − background luminescence
] ]
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2.6  Magnetic nanoparticle uptake
0.2 µl Polymag or 0.1 µl nTmag nanoparticles were incu-
bated with 0.2 µg or 0.3 µg pEGFPN1 plasmid (encoding the 
green fluorescent protein, GFP) for 15 min, then added to 
cultures which were immediately placed on the magnet array 
(30 min oscillation at 2 Hz frequency, 0.2 mm horizontal 
displacement). GFP expression indicates cellular uptake of 
nanoparticles and expression of the plasmid. Fluorescence 
was observed after 48 h incubation using a Leica DM IL 
LED fluorescent microscope (Newcastle Upon Tyne, UK) 
or Nikon fluorescent microscope (Amsterdam, Netherlands).
2.7  Statistics
If not stated otherwise, the data were presented as mean ± SD 
of values from at least three experiments. Statistical signifi-
cance was determined by a one-way ANOVA followed by 
a Bonferroni post hoc test (multiple comparison test) with 
p > 0.05 considered as not significant.
3  Results
The magnetic field surrounding an array of magnets was 
measured to inform a theoretical prediction of magnetic 
nanoparticle behavior within such a field. Cancer cell lines 
were exposed to magnetic nanoparticles in the presence of 
an oscillating magnetic field gradient to assess their potential 
for inducing cytotoxicity.
3.1  Magnetic field measurements
Magnetic field (flux density) measurements above the mag-
net array were determined at the magnet face, and base of a 
culture plate immediately above the array (see Fig. 2).
3.2  Numerical modeling
Based on the magnetic field measurements shown in Fig. 2, 
magnetic field distribution and gradient flux density calcula-
tions were performed for the magnet array set up used for 
conducting experiments. These estimates provide insight 
into the principles behind the manipulation of MNPs.
The magnetic fields and the field gradients produced by 
the magnet array were calculated (x-, y-, z-axes). The mag-
netic force experienced by the MNPs and the velocity of the 
MNPs relative to the carrier fluid were calculated using the 
numerical model described in the methods section. Contour 
plots of the parameters mentioned above for 1 mm above the 
magnet array (z-axis) provide a better understanding, aiding 
in the positioning of the cells and MNPs (see Figs. 3, 4).
Field gradient decreases with distance (z-axis) from the 
magnet face (Fig. 4). Here, it is important to note that the 
internal diameter of a cell culture well is 6.5 mm (typical 96 
well plate). Figure 4b and 2d plot in 4(c) demonstrate that 
the magnetic flux gradient is relatively low in the center and 
higher near the magnet’s edge.
Field gradient graphs showing x-axis against y-axis 
(horizontal magnet displacement during array oscillation: 
0 mm and 0.1 mm) should provide us with insights into the 
changes occurring in the magnetic field and field gradient 
when the magnet array is moved back and forth along the 
x-axis (see Fig. 5). The magnetic field flux (Fig. 5a) and 
field gradient data (Fig. 5b) demonstrate that the magnetic 
field shifts in the y-axis over 0–0.1 mm, a relatively short 
distance.
The magnetic force, ( F
m
 ), and the velocity of the MNPs 
will be directly proportional to the field gradient (B2): i.e., 
they will appear as a crater in 3D at 1 mm (z-axis). And, the 
displacement of the MNPs will be inversely proportional to 
the time-varying frequency.
Fig. 2  Hall probe measurements of flux density. A Hall probe (indi-
cated as blue) was used to determine magnetic field B (flux density) 
at a 0 mm above the 3 × 3 magnet array and b the base of a culture 
plate well (1  mm above magnet face). c Measured field B values 
for method described in (a). d Measured field B values for method 
described in (b). Values are in millitesla (mT), average of three meas-
urements from three different magnet arrays. Red—South; Purple—
North
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3.3  Cytotoxicity of neuroblastoma cancer cells
Cytotoxicity was successfully induced in both cancer cell 
lines following exposure to magnetic nanoparticles and an 
oscillating magnetic array. Level of cytotoxicity was depend-
ent on frequency and displacement of the magnet arrays 
determined by membrane integrity assay (Fig. 6). Viability 
decreased with increasing oscillating frequency and increas-
ing amplitude of array oscillation. Polymag MNPs, with 
3 Hz/0.3 mm oscillation reduced viability to 70.5 ± 6.0%.
3.4  Nanoparticles were endocytosed 
by neuroblastoma cells
To establish that the nanoparticles were endocytosed by 
neuroblastoma cells, Polymag nanoparticles were coated 
with plasmids encoding GFP, before incubation with cells, 
in the presence of a magnetic array. Control cells were 
included (plasmid only, no MNPs) and exposed to the 
magnetic field. Green fluorescence was observed by cells 
which had endocytosed MNPs and subsequently expressed 
GFP from the adsorbed plasmid (Fig. 7a). As expected, 
GFP expression was not observed in control cells. There 
was negligible uptake with the control containing plasmid 
Fig. 3  2D model of flux den-
sity above magnetic array. A 
magneto-static (vector potential) 
algorithm was used to calculate: 
(a) magnetic field (flux density) 
distribution over the 3 × 3 
magnet array at 1 mm above the 
magnets; and (b) magnetic field 
(flux density) distribution at 0.5, 
1, 1.5 mm above the magnets 
(z-axis). 3 and − 3 mm distance 
represent magnet edges. Legend 
shows (x, y, z coordinates in 
mm)
Fig. 4  Modeling of gradient flux density above a static magnet. a 3D 
model of the 3 × 3 magnet array used for gradient flux density calcu-
lations. b The field gradient distribution (gradient flux density) at 0.5, 
1, and 1.5  mm along the z-axis (vertically above centre of magnet, 
x = y = 0). c 2D plot of the field gradient distribution (gradient flux 
density) across the midline of a magnet at 0.5, 1 and 1.5 mm above 
the magnet face
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only. This demonstrates that the cytotoxicity observed 
(Fig. 6) can be attributed to internalization of MNPs.
3.5  Cytotoxicity of hepatocellular carcinoma cells
At the highest oscillation frequency tested (4 Hz), viability 
of Hep G2 cells in the presence of MNPs had the lowest 
viability (53.1 ± 11.4%; Fig. 8).
3.6  Nanoparticles were endocytosed 
by hepatocellular carcinoma cells
GFP expression by Hep G2 carcinoma cells indicated 
endocytosis of MNPs and subsequent plasmid expression 
(Fig. 9a). As before, GFP expression was not observed in 
control cultures and there was negligible uptake with control 
cells containing plasmid only (no MNPs). This demonstrates 
that the cytotoxicity observed (Fig. 8) can be attributed to 
internalization of MNPs.
3.7  Magnet array optimization
Based on the observed results, we propose that magnet array 
design could be improved to enhance performance when 
delivering MNPs to a cell monolayer within a round culture 
well. To address this goal, we evaluated different magnet 
shapes and arrangements using our model, with the aim of 
identifying improved field gradient experienced by MNPs/
cells. Two different types of magnet array were compared 
with the magnet array used in this study via numerical mod-
eling. A magnet array made up of pyramidal magnets, and 
a custom-shaped Halbach magnet array based on [18, 19] 
were taken into consideration (Fig. 10). The magneto-static 
algorithm described earlier was used to calculate magnetic 
field distributions (Fig. 11) for the magnet arrays shown in 
Fig. 10. The field strength values at 1 mm above the magnet 
apex (z-axis) were used to calculate the field gradient.
From Fig. 12, we can infer that the gradient field values at 
1 mm and 1.5 mm (z-axis) were higher for the magnet array 
made up of pyramid-shaped magnets and optimized Hal-
bach magnet array than the magnet array used in this study. 
Optimized Halbach array produced better gradient field out 
of all three designs. Moreover, Fm is directly proportional 
to the gradient magnetic field (see Eq. 9). These numerical 
calculations shown in Fig. 12 demonstrate that prospects are 
available for further magnet array optimization to enhance 
the manipulation of magnetic nanoparticles.
Fig. 5  Gradient flux density at culture well surface (adherent cell 
layer) during horizontal oscillation of the magnetic array. a 2D plot of 
the magnetic field (flux density) for 0 mm (x-axis) and 0.1 mm shifted 
along the y-axis. b The field gradient (gradient flux density) for 0 mm 
(x-axis) and 0.1 mm shifted along the y-axis
Fig. 6  Magneto-mechanically induced cytotoxicity in SHSY-5Y neu-
roblastoma cells, exposed to magnetic nanoparticles and a time-vary-
ing magnetic field gradient. n = 3. Control–MNPs only and no mag-
netic field. Asterisk denotes P ≤ 0.05
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4  Discussion
To understand the mechanism behind the observed cytotox-
icity mediated by MNPs, it is essential to study the mag-
netic field and the field gradients produced by the magnet 
array. Previous studies on a static magnetic array suggest 
that the magnet does accelerate the sedimentation of MNPs 
onto adherent cells by overcoming diffusion-limited accu-
mulation [13]. This sedimentation rate can be influenced by 
varying the size of the MNPs and/or the distance between 
the magnet array and the cell culture plate [13]. Further-
more, a stronger axial magnetic force, achieved using an 
alternating magnetic pole array rather than a unidirectional 
magnet array, improves the accumulation rate [14]. There 
are some interesting questions posed by the results of the 
present study regarding the mechanism behind this unique 
biophysical technique which facilitates the damage of cells 
via a laterally oscillating high gradient magnet array. Based 
on our model, the field gradient should be considered the 
most dynamic variable when calculating the Fm (N) from 
(9). Thus, high field gradient will increase the force acting 
upon the magnetic nanoparticles. Assuming that the mag-
netic array will move without any drag or delay in the field 
over a displacement distance of 0.2 mm.
A scrutiny of the magnetic flux density ( B ), its squared 
gradient ( B2 ), the magnetic force ( Fm ) and the velocity of 
the MNPs (Figs. 2, 3, 4, 5 and numerical calculations) sug-
gests that these values vary within a single well (internal 
diameter − 6.5 mm) of the (static) cell culture vessel when 
an alternating-pole magnet array is moved back and forth 
underneath. It is already evident that the Fm overcomes some 
of the viscous drag force of culture medium, since the appli-
cation of this alternating-pole magnet array resulted in the 
accumulation of 90% of MNPs at the bottom of the plate 
after 20 min of exposure to a static array [14]. When most 
of the particles are in contact with the monolayer of cultured 
cells, the nanoparticles will experience a field gradient and a 
homogenous field (Figs. 3, 4, 5). MNPs in the gradient field 
will experience a translational motion and in the homogene-
ous field will experience a rotational motion—in addition to 
the random Brownian movement (walk) [12]. The magne-
tophoretic parameter ( 휉 ), i.e., the manipulability of 100 nm 
(HD)-sized MNPs used in this study, can be calculated using 
(14), and the displacement values resulting from the veloc-
ity do predict that the nanoparticles undergo a translational 
movement.
Fig. 7  Endocytosis of Polymag MNPs by SHSY-5Y cells was 
confirmed by GFP expression. a Fluorescence micrograph of 
GFP + SHSY-5Y cells superimposed on counterpart phase contrast 
micrograph, demonstrating expression of a GFP-encoding plasmid 
carried by Polymag MNPs (with oscillating magnetic field, fre-
quency = 2  Hz, amplitude = 0.2  mm). b Fluorescence micrograph of 
GFP- SHSY-5Y cells superimposed on counterpart phase contrast 
micrograph, demonstrating absence of expression of GFP when incu-
bated with plasmid without Polymag MNPs as a vector (with oscillat-
ing magnetic field, frequency = 2 Hz, amplitude = 0.2 mm)
Fig. 8  Magneto-mechanically-induced cytotoxicity in Hep G2 car-
cinoma cells, exposed to magnetic nanoparticles and a time-varying 
magnetic field gradient. n = 3. Control–MNPs only and no magnetic 
field. Asterisk denotes P ≤ 0.05
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Hence, we can advocate from our calculations that the 
MNPs will experience oscillating horizontal translational 
motion when the magnet array is moved laterally (− 0.1 to 
0.1 mm in the x-axis for 0.2 mm displacement or − 0.15 
to 0.15 mm for 0.3 mm displacement) underneath the cell 
culture plate. And this displacement of MNPs is inversely 
proportional to the time-varying frequency of the magnet 
array movement. In other words, the translational movement 
of the MNPs, induced by the time-varying magnet array will 
reduce, if we increase the time-varying frequency. But, the 
number of movement cycles will increase.
An important point to note is that MNPs tend to form 
aggregates, and this may have an impact on the translational 
motion of the MNPs [4]. The low displacement values may 
be due to viscous damping and displacement might be higher 
when the nanoparticles form aggregates. However, this back 
and forth motion, through the influence of a time-varying 
field gradient, should have induced mechanical stress on the 
surface/inside of the cells, which in turn should increase cell 
death; this effect is facilitated by the magnet’s displacement. 
Even though the displacement values are low, the mechani-
cal manipulation would cause stress for 30-min exposure at 
2 Hz, as the total number of oscillations would be 3600, i.e., 
120 cycles per minute. And, we should not exclude nanopar-
ticle clusters. The sizes of animal cells are usually between 
0.01 and 0.1 mm, and cell cytoplasm has a higher viscos-
ity than the surrounding cell culture medium. So, gradient 
magnetic field-assisted movement of MNPs should reduce 
once the MNPs are endocytosed by cells; however, there 
are studies validating the motility of small molecules within 
cytoplasm [20].
This spatio-temporal behavior parameter, i.e., the oscil-
lating motion of the MNPs, must be responsible for the 
increase in the cytotoxicity of the neuroblastoma cancer 
cells. In vitro numerical investigation suggests that magnet 
geometry influences the collection time of the magnetic par-
ticles moving through a high viscosity fluid. Furthermore, 
we use cylindrical shape magnets with an aspect ratio of 
1:1.66; this is comparable to the magnet geometry used for 
in vivo studies; this is cylindrical—not conical—and has an 
aspect ratio of 1:1 [15]. Gradient magnetic field being the 
most dominant parameter to manipulate MNPs in vitro and 
Fig. 9  Endocytosis of nTmag MNPs by Hep G2 carcinoma cells 
was confirmed by GFP expression. a Fluorescence micrograph of 
GFP + Hep G2 cells superimposed on counterpart phase contrast 
micrograph, demonstrating expression of a GFP-encoding plas-
mid carried by nTmag MNPs (with oscillating magnetic field, fre-
quency = 2  Hz, amplitude = 0.2  mm). b Fluorescence micrograph 
of GFP-Hep G2 cells superimposed on counterpart phase contrast 
micrograph, demonstrating absence of expression of GFP when incu-
bated with plasmid without nTmag MNPs as a vector (with oscillat-
ing magnetic field, frequency = 2 Hz, amplitude = 0.2 mm)
Fig. 10  Proposed magnet array with pyramid-shaped magnets (a); 
optimized Halbach magnet array (b)
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in vivo, it is possible to optimize this parameter using dif-
ferent types of magnet arrays as demonstrated in this study 
and other similar studies [18].
Such numerical studies will help us to understand the 
principles behind time-varying magnet array-induced cyto-
toxicity and facilitate the optimization of this process. From 
a numerical perspective, the size and magnetic susceptibility 
of the nanoparticles used (Polymag, nTmag—100 nm), the 
distance between the magnet array and the cell culture plate 
(1 mm), the rapid accumulation of MNPs by the use of an 
alternate pole magnet array, and the variation in magnetic 
force mediated by a time-varying field gradient are behind 
the increased cytotoxicity of cancer cells.
5  Conclusions
Therefore, from our field measurements, numerical calcu-
lations and our cytotoxicity experiments, surface function-
alized, super paramagnetic iron oxide nanoparticle at low 
concentrations was externally manipulated, using a time-
varying field gradient technique (at very low frequencies, 
i.e., 1–4 Hz), to induce magneto-mechanical cell death in 
cancer cells. This is a key to the effective inducement of 
minimally invasive cytotoxicity in cancer cells in physiologi-
cal and clinical settings; further multidisciplinary research is 
required to make substantial progress in this area.
Fig. 11  Magneto-static (vector potential) algorithm-based numeri-
cal calculations: (a) magnetic field (flux density) distribution over 
the 3 × 3 magnet array (pyramid shaped magnets) at 1 mm above the 
magnets (b) magnetic field (flux density) distribution over the opti-
mized Halbach magnet array at 1 mm above the magnets
Fig. 12  Field gradients are predicted to differ between magnets of different shapes. a 2D plot of the magnetic field gradient (gradient flux den-
sity) at 1.5 mm along the z-axis. b 2D plot of the magnetic field gradient (gradient flux density) at 1 mm along the z-axis
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